Aflibercept Injection for Proliferative Diabetic Retinopathy
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the ocular and systemic safety of intravitreal aflibercept injection in patients
undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy.